Accueil
Martin Billger
Martin Billger
Affiliations
Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden. Electronic address: Martin.Billger@astrazeneca.com.
Publications (2)
A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.
Regulatory toxicology and pharmacology : RTP
Avec:
Martin Billger
,
Jason Kirk
,
Jane Chang
,
Agathe Bédard
,
Bassem Attalla
,
Solomon Haile
,
Magnus Söderberg
A comprehensive analysis of liver safety across zibotentan oncology trials: knowledge of the past offers new perspectives on the present.
Expert opinion on drug safety
Avec:
Anna Fettiplace
,
Sherri Matis-Mitchell
,
Oleksandr Molodetskyi
,
Malin Söderbergh
,
Jan Oscarsson
,
Min Lin
,
Srivathsa Ravikiran
,
Martin Billger
,
Philip Ambery
Réseau de co-auteurs
Jason Kirk
1 collaboration
Jane Chang
1 collaboration
Agathe Bédard
1 collaboration
Bassem Attalla
1 collaboration
Solomon Haile
1 collaboration
Magnus Söderberg
1 collaboration
Anna Fettiplace
1 collaboration
Sherri Matis-Mitchell
1 collaboration
Oleksandr Molodetskyi
1 collaboration
Malin Söderbergh
1 collaboration
Jan Oscarsson
1 collaboration
Min Lin
1 collaboration
Srivathsa Ravikiran
1 collaboration
Philip Ambery
1 collaboration